AMERICAN JOURNAL OF CHINESE MEDICINE, published by WORLD SCIENTIFIC PUBL CO PTE LTD, is a leading peer-reviewed journal dedicated to the field of complementary and alternative medicine, with a particular focus on the rich traditions and practices of Chinese medicine. Since its establishment, the journal has provided a platform for innovative research and reviews that explore both empirical and theoretical aspects of Chinese medicinal practices, serving an essential role in bridging Eastern and Western medical paradigms. With an impressive impact factor, categorized in the Q1 quartile for both Complementary and Alternative Medicine and Medicine (miscellaneous) in 2023, it ranks as the 4th out of 105 journals in its field according to Scopus, placing it in the 96th percentile. Researchers and students alike will find valuable insights within its pages, as it aims to disseminate high-quality research that contributes to the understanding and application of Chinese medicine in modern healthcare contexts. The journal does not currently offer Open Access options but ensures rigorous academic standards and comprehensive reviews that reflect the evolving landscape of medicine. Located in Singapore, it has emerged as a vital resource for professionals seeking to enhance their knowledge and practice in the dynamic area of complementary health.

Alternative Therapies in Health and Medicine is a distinguished peer-reviewed journal, published by InnoVision Professional Media, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has provided a platform for the dissemination of research focusing on holistic approaches to healthcare, innovative therapies, and integrative practices. With an ISSN of 1078-6791 and an E-ISSN of 1078-6791, it offers valuable insights crucial for researchers, healthcare professionals, and students alike. While the journal currently holds a Q3 ranking in both Complementary and Alternative Medicine and Miscellaneous Medicine categories as of 2023, it aims to foster an inclusive dialogue surrounding non-conventional medical practices and their integration into mainstream health paradigms. As the journal continues its journey through 2024, it remains steadfast in its objective to enrich academic discourse and promote evidence-based alternative therapies. Access to the journal is available through institutional subscriptions, enhancing its reach within the global academic community.

Complementary Medicine Research, published by KARGER, is a leading open-access journal dedicated to the field of complementary and alternative medicine. With an ISSN of 2504-2092 and an E-ISSN of 2504-2106, this journal serves as an essential platform for researchers, professionals, and students to disseminate innovative research findings and explore the latest advancements in the field. Positioned in the Q2 quartile for Complementary and Alternative Medicine and ranking 48th out of 105 in Scopus, the journal showcases high-quality, peer-reviewed articles that contribute to a deeper understanding of the efficacy, safety, and application of complementary therapies. Based in Switzerland, the journal is committed to promoting an integrative approach to medicine, aiming to bridge the gap between conventional and alternative practices. The open-access format ensures that knowledge is accessible to a global audience, enhancing collaboration and dialogue among scholars and practitioners interested in holistic health approaches.

Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

PHARMACEUTICAL BIOLOGY, published by Taylor & Francis Ltd, is a prominent open-access journal that has been a cornerstone of research in the life sciences since its convergence in 1961. With a strong focus on Complementary and Alternative Medicine, Pharmaceutical Science, and Drug Discovery, this journal is dedicated to disseminating groundbreaking research that intersects pharmaceuticals and biology. Acknowledged for its rigorous peer-review process, it holds a prestigious Q1 ranking in Pharmaceutical Science and exemplifies the commitment to quality and impact in the field, boasting an impressive Scopus rank of #14/105 in the complementary and alternative medicine category. Researchers keen on advancing their knowledge in these fields will find PHARMACEUTICAL BIOLOGY an invaluable resource, offering accessibility since its shift to open access in 2017. This journal presents a platform for innovative studies that contribute to the evolving understanding of pharmaceutical applications and biological interactions, serving as an essential hub for researchers, professionals, and students alike.

Explore - The Journal of Science and Healing is a reputable publication by Elsevier Science Inc, dedicated to advancing the fields of complementary and alternative medicine, chiropractic practices, and health professions. With an ISSN of 1550-8307 and E-ISSN of 1878-7541, this journal cultivates a dynamic platform for researchers, practitioners, and scholars to disseminate innovative findings, theoretical advancements, and clinical applications across a range of interdisciplinary studies. Covering a broad spectrum from 2005 to 2024, it holds esteemed rankings in notable categories such as Chiropractics (Q2), Complementary and Alternative Medicine (Q2), and Nursing (Q2), underscoring its commitment to quality scholarship and impactful research. While currently operating under a subscription model, the journal aims to foster discourse and collaboration within the health sciences community, ultimately contributing to enhanced patient care and wellness strategies. Explore offers invaluable insights for those at the forefront of science and healing, ensuring its role as a vital resource in shaping the future of these evolving fields.

The Chinese Journal of Integrative Medicine, published by SPRINGER, serves as a pivotal platform for advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has been committed to disseminating high-quality research and innovative practices that integrate traditional Chinese medicine with modern medical science. With an impressive categorization in the 2023 metrics, ranking Q2 in Complementary and Alternative Medicine and Q3 in both Medicine (miscellaneous) and Pharmacology (medical), the journal highlights its recognition within the global academic landscape. Researchers and practitioners alike can benefit from its rigorous peer-reviewed articles, making significant contributions to the understanding and application of integrative health strategies. While it currently does not support open access, the journal remains a key resource for those dedicated to exploring the synergy between ancient practices and contemporary medical approaches, thus enhancing patient care and outcomes.

BMC Complementary Medicine and Therapies is a leading open-access journal published by BMC in the United Kingdom, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 2020, this journal has rapidly gained recognition, achieving a prestigious Q1 ranking in the category of Complementary and Alternative Medicine as of 2023, and ranking #18 out of 105 in the Scopus database, placing it in the 83rd percentile among its peers. The journal’s mission is to disseminate high-quality research that contributes to a better understanding of the efficacy, safety, and practical application of complementary therapies. With its open-access model, BMC Complementary Medicine and Therapies ensures that valuable research findings are freely accessible to researchers, healthcare practitioners, and students alike, fostering collaboration and innovation across disciplines. The journal publishes original research, reviews, and clinical studies, providing a comprehensive platform for the exploration of diverse therapeutic modalities.

European Journal of Integrative Medicine is a prestigious academic publication under the esteemed Elsevier Science Inc., dedicated to advancing knowledge in the field of Complementary and Alternative Medicine. With an ISSN of 1876-3820 and an E-ISSN of 1876-3839, this journal serves as a pivotal platform for researchers, professionals, and students alike, aiming to explore the integration of holistic practices with conventional medicine. With a Q2 ranking in the 2023 Scopus category for Complementary and Alternative Medicine, and a commendable percentile of 75th, the journal underscores its significance in fostering scholarly discourse and supporting innovative research from 2009 to 2024. The European Journal of Integrative Medicine does not currently offer open access options, encouraging subscription-based access that promotes the quality of published research. This journal is subsequently an essential resource for anyone seeking to deepen their understanding of integrative health approaches and their clinical applications in contemporary medicine.

Chinese Herbal Medicines, published by Elsevier Singapore Pte Ltd, is a distinguished journal dedicated to the exploration and advancement of research in the fields of Complementary and Alternative Medicine and Pharmacology. Since its transition to Open Access in 2020, the journal has significantly broadened its reach, facilitating the dissemination of valuable knowledge to researchers, practitioners, and academics worldwide. With an impressive Q1 ranking in Complementary and Alternative Medicine and a notable Q2 ranking in both Pharmacology categories for 2023, it is recognized for its impactful contributions to the understanding of herbal treatments and their therapeutic applications. Situated in The Netherlands and numerically indexed under ISSN: 1674-6384, the journal aims to provide a platform for innovative studies, analytical reviews, and clinical research that explore the efficacy, safety, and socio-economic factors associated with herbal medicines. The HIndex reflects its growing influence in the scientific community, while Scopus rankings position the journal favorably within its respective fields, making it a vital resource for any serious scholar engaged in herbal medicine studies.